Haematological sequelae in the post-acute phase of symptomatic SARS-CoV-2 infection

• Published in: Internal and emergency medicine Vol. 19; no. 1; pp. 125 - 133
• Main Authors: Bergamaschi, Gaetano, Barteselli, Chiara, Calabretta, Francesca, Lenti, Marco Vincenzo, Merli, Stefania, Rossi, Carlo Maria, Di Sabatino, Antonio
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 2024; Springer Nature B.V
• Subjects: Cognitive ability; Comorbidity; Complications; COVID-19; Dyspnea; Hematology; Im - Original; Immunoglobulin M; Immunological memory; Infections; Internal Medicine; Leukocytes (eosinophilic); Lymphocytes B; Medicine; Medicine & Public Health; Memory; Memory cells; Olfaction; Procalcitonin; Renal function; Severe acute respiratory syndrome coronavirus 2; Immune responses; Memory B cells; Anaemia; Thromboembolism; Lymphocytes; Bleeding
• ISSN: 1828-0447; 1970-9366
• DOI: 10.1007/s11739-023-03459-6

Many patients surviving SARS-CoV-2 infection suffer from long-term symptoms (long COVID or post COVID) such as shortness of breath, fatigue, loss of taste or smell and cognitive deterioration. However, few data are available concerning blood cell counts and haematological parameters during the post-COVID period. We analysed haematological data from 83 patients previously admitted to the internal medicine unit of our institution because of symptomatic SARS-CoV-2 infection; all data were obtained within 1–12 months from disease onset. A control group of 70 apparently healthy, age- and sex-matched COVID-19 negative individuals was assessed for comparison. Blood cell counts improved in the post-COVID period, but 81% of patients had persistent abnormalities, compared with 50% in the control group, p < 0.001. Most common haematological findings included anaemia (40%), reduced lymphocyte (43%) or eosinophil counts (38%) and low IgM memory B cells and correlated with advanced age, number of chronic comorbidities, female gender, altered renal function, reduced baseline Hb and procalcitonin concentrations and increased RDW. Data on lymphocytes and IgM memory B cells show that impaired immune responses may persist for up to one year in the post-COVID period, possibly contributing to long-term symptoms, especially in female patients.